An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
Incyte Corporation
Study ID
NCT03147742
Status
Approved For Marketing

Conditions

  • Graft-versus-host Disease (GVHD)

Eligibility Criteria

Sex
ALL
Age
12 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Ruxolitinib — DRUG
    Ruxolitinib starting dose level 10 mg orally, twice daily (BID).

Study Details

To provide ruxolitinib through an expanded access program for the treatment of graft-versus-host disease (GVHD) in United States to patients who are ineligible or unable to participate in any actively enrolling Incyte-sponsored clinical studies for ruxolitinib in the treatment of GVHD.

Key Dates

Status verified
Jun 2022

Locations (33)

FacilityCityStateZIPSite coordinators
Mayo Clinic ArizonaPhoenixArizona85054-
Cancer Transplant Institute at HonorHealthScottsdaleArizona85258-
City of Hope Medical CenterDuarteCalifornia91010-
Scripps ClinicLa JollaCalifornia92037-
Colorado Blood Cancer InstituteDenverColorado80218-
Nicklaus Children's HospitalMiamiFlorida33155-
Blood & Marrow Transplant CenterOrlandoFlorida32804-
Northwestern Memorial HospitalChicagoIllinois60611-
University of Illinois ChicagoChicagoIllinois60612-
Indiana Blood and Marrow TransplantationIndianapolisIndiana46237-
Cancer Center of KansasWichitaKansas67214-
Massachusetts General HospitalBostonMassachusetts02214-
University of Michigan Comprehensive Cancer CenterAnn ArborMichigan48109-5271-
Spectrum HealthGrand RapidsMichigan49503-
Mayo Clinic MinnesotaRochesterMinnesota55905-
Washington University School of MedicineSt LouisMissouri63110-
Hackensack University Medical CenterHackensackNew Jersey07601-
Rutgers Cancer InstituteNew BrunswickNew Jersey08903-
New Mexico Cancer CenterAlbuquerqueNew Mexico87109-
Memorial Sloan Kettering Cancer CenterNew YorkNew York10065-
Weill Cornell Medical CollegeNew YorkNew York10021-
Cleveland ClinicClevelandOhio44195-
Ohio State UniversityColumbusOhio43210-
Oregon Health & Science UniversityPortlandOregon97239-
Gettysburg Cancer CenterGettysburgPennsylvania17325-
Allegheny Health Network Cancer InstitutePittsburghPennsylvania15224-
Greenville Health System Cancer InstituteGreenvilleSouth Carolina29615-
Avera Research InstituteSioux FallsSouth Dakota57105-
Texas OncologyDallasTexas75246-
Houston MethodistHoustonTexas77030-
Methodist HospitalSan AntonioTexas78229-
Fred Hutchinson Cancer Research CenterSeattleWashington98109-1024-
Medical College of WisconsinMilwaukeeWisconsin53226-

Find similar trials in Phoenix, AZ

By research site
Mayo Clinic Arizona· Phoenix, AZCancer Transplant Institute at HonorHealth· Scottsdale, AZCity of Hope Medical Center· Duarte, CAScripps Clinic· La Jolla, CAColorado Blood Cancer Institute· Denver, CONicklaus Children's Hospital· Miami, FL

Related Studies